CD8A and neoplasm: There were no differences in the frequency of CD8+ T cells between groups in the spleen or draining lymph nodes; however, mice that received butyrate-treated cells had a statistically significantly greater frequency of CD8+ T cells within the tumor (Figure 5D) than mice that received either PBS or untreated cells.